Re-evaluation of clinical dementia diagnoses with pittsburgh compound B positron emission tomography.

M Degerman Gunnarsson, M Lindau, Alexander Santillo, A Wall, H Engler, L Lannfelt, H Basun, L Kilander

Research output: Contribution to journalArticlepeer-review

175 Downloads (Pure)

Abstract

There is an overlap regarding Pittsburgh compound B (PIB) retention in patients clinically diagnosed as Alzheimer's disease (AD) and non-AD dementia. The aim of the present study was to investigate whether there are any differences between PIB-positive and PIB-negative patients in a mixed cohort of patients with neurodegenerative dementia of mild severity regarding neuropsychological test performance and regional cerebral glucose metabolism measured with [(18)F]fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET).
Original languageEnglish
Pages (from-to)472-481
JournalDementia and Geriatric Cognitive Disorders Extra
Volume3
Issue number1
DOIs
Publication statusPublished - 2013

Bibliographical note

The information about affiliations in this record was updated in December 2015.
The record was previously connected to the following departments: Department of Psychogeriatrics (013304000)

Subject classification (UKÄ)

  • Psychiatry
  • Geriatrics

Fingerprint

Dive into the research topics of 'Re-evaluation of clinical dementia diagnoses with pittsburgh compound B positron emission tomography.'. Together they form a unique fingerprint.

Cite this